June 7, 2023
Clinical Case Reports
Alexandria University (Egypt)
"Conclusion
... [W]e included 14 studies with a total of 29 cases, 59% of which were males and 41% were females. Following [COVID-19] vaccination, GBS [Guillain-Barré syndrome] typically appeared 14.4 days later. Most cases developed GBS after receiving the AstraZeneca/Oxford vaccine."
© 2023 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
document
adverse events,COVID-19,neurological disorders,vaccines